earnings
PY
NASDAQ · PYPD
PolyPid Ltd.
Healthcare · Biotechnology
$4.95
Down-$0.05 (-1.01%)
Updated Oct 9, 2026, 12:20 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 40.46M
- P/E ratio
- -1.48
- Dividend yield
- 0.00%
- 52-week range
- $3.06 – $5.73
- Volume
- 115.1K
- Avg. volume
- 80.67K
Price performance · PYPD
PYPD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
PYPD closed at $4.95 after 20 trading sessions, down 4.07% for the selected period.
- Last close
- $4.95
- Period change
- -4.07%
- Period low
- $4.95
- Period high
- $5.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $5.11 | $5.19 | $4.90 | $4.95 | 115.1K |
| Oct 6, 2026 | $5.22 | $5.24 | $5.05 | $5.13 | 86.56K |
| Oct 5, 2026 | $5.28 | $5.33 | $5.03 | $5.20 | 102.02K |
| Oct 2, 2026 | $5.49 | $5.55 | $5.06 | $5.19 | 168.31K |
| Oct 1, 2026 | $5.30 | $5.47 | $5.28 | $5.37 | 118.78K |
| Sep 30, 2026 | $5.27 | $5.355 | $5.16 | $5.27 | 47.39K |
| Sep 29, 2026 | $5.40 | $5.40 | $5.23 | $5.29 | 66.04K |
| Sep 28, 2026 | $5.22 | $5.4299 | $5.1863 | $5.31 | 76K |
| Sep 25, 2026 | $5.33 | $5.45 | $5.22 | $5.22 | 44.77K |
| Sep 24, 2026 | $5.27 | $5.365 | $5.19 | $5.36 | 60.46K |
| Sep 23, 2026 | $5.43 | $5.43 | $5.10 | $5.27 | 69.13K |
| Sep 22, 2026 | $5.19 | $5.4644 | $5.19 | $5.45 | 127.01K |
| Sep 21, 2026 | $5.22 | $5.345 | $5.12 | $5.17 | 40.76K |
| Sep 18, 2026 | $5.06 | $5.30 | $5.06 | $5.21 | 66.36K |
| Sep 17, 2026 | $5.25 | $5.34 | $5.03 | $5.03 | 104.97K |
| Sep 16, 2026 | $5.15 | $5.22 | $5.00 | $5.21 | 76.49K |
| Sep 15, 2026 | $5.32 | $5.33 | $5.03 | $5.16 | 81.67K |
| Sep 14, 2026 | $5.18 | $5.35 | $5.14 | $5.33 | 180.69K |
| Sep 11, 2026 | $5.20 | $5.24 | $5.04 | $5.15 | 100.18K |
| Sep 10, 2026 | $5.20 | $5.3816 | $5.13 | $5.16 | 69.65K |
Latest PYPD news
The latest Smart Investors Daily articles mentioning PYPD.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

